Publications by authors named "Evelyn Exner"

Claim this Profile
F
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Antje Blank, Nicolas Hohmann, Marlen Dettmer, Anette Manka-Stuhlik, Gerd Mikus, Evelyn Exner

Clin Transl Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a diabody-based (177)Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model.
Tobias Weber, Benedikt Bötticher, Michaela A E Arndt, Walter Mier, Max Sauter, Evelyn Exner

Cancer Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.
Tobias Weber, Athanasios Mavratzas, Stefan Kiesgen, Stephanie Haase, Benedikt Bötticher, Evelyn Exner

J Immunol Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-level production of a humanized immunoRNase fusion protein from stably transfected myeloma cells.
Jürgen Krauss, Evelyn Exner, Athanasios Mavratzas, Siegfried Seeber, Michaela A E Arndt

Methods Mol Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis